Yu Sunakawa

39PUBLICATIONS

183CO-AUTHORS

Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jul 01, 2026

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Jun 12, 2026

Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations.

|May 23, 2026

Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens.

|May 20, 2026

Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.

|Mar 30, 2026

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.

Yuqing Duan, Tadayoshi Hashimoto, Taro Shibuki

|Feb 28, 2026

Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.

Daisuke Kotani, Eisuke Inoue, Tadamichi Denda

Pageof 7

Frequent Collaborators

13 joint publications

Takayuki Yoshino

10 joint publications

Yoshiaki Nakamura

10 joint publications

Hideaki Bando

Eiji Oki

Hiroya Taniguchi

Hisateru Yasui

Taroh Satoh

Yoshito Komatsu

Tadamichi Denda

Kentaro Yamazaki

Frequent Collaborators

13 joint publications

Takayuki Yoshino

10 joint publications

Yoshiaki Nakamura

10 joint publications

Hideaki Bando

9 joint publications

Eiji Oki